Table 1.
Clinical and pathological characteristics of 37 lung cancer patients and their tumors
| Patient ID | Age (years)/gender | Smoking history (years) | Differentiation | TNM stage | Site | Histological cell type | Tumor size (cm3) | Metastasis |
|---|---|---|---|---|---|---|---|---|
| LC-00158 | 44/F | N | Moderately | IA | LUL | ADC | 1.86 | N |
| LC-00368 | 70/M | 40 | Poorly | IIB | RLL | SCC | 18.85 | N |
| LC-00536 | 60/F | N | Poorly | IIIA | RML | ADC | 1.00 | Y |
| LC-00666 | 71/F | N | Moderately | IB | LLL | SCC | 31.41 | N |
| LC-00592 | 62/M | 40 | Poorly | IIIB | RLL | ADC | 126 | Y |
| LC-00234 | 72/M | 50 | Poorly | IIB | RLL | SCC | 81.73 | N |
| LC-00576 | 66/M | 45 | Poorly | IA | RLL | ADC+SCC | 2.25 | N |
| LC-00088 | 52/M | 20 | Poorly | IB | RUL | SCC | 25.13 | Y |
| LC-00453 | 61/F | N | Poorly | IIIA | RLL | ADC | 13.50 | Y |
| LC-00374 | 76/M | 30 | Moderately | IB | RLL | SCC | 14.14 | N |
| LC-00178 | 73/M | 30 | Moderately | IB | RML | ADC | 13.50 | N |
| LC-00144 | 63/M | 7 | Moderately | IB | RLL | ADC | 16.49 | N |
| LC-00507 | 73/M | 50 | Poorly | IB | RUL | SCC | N | |
| LC-00083 | 62/M | N | Poorly | IIIB | RML | SCC | 108.00 | Y |
| LC-00022 | 60/F | N | Moderately | IB | LUL | ADC | 5.24 | N |
| LC-00001 | 59/M | 45 | Moderately | IIA | LUL | SCC | 108.00 | N |
| LC-00827 | 70/M | 50 | Poorly | IIA | RLL | SCC | 40.00 | Y |
| LC-00877 | 58/M | 35 | Poorly | IB | LUL | SCC | 32.00 | N |
| LC-00781 | 61/M | 40 | Poorly | IIA | RLL | SCC | 12.76 | Y |
| LC-00343 | 59/M | 40 | Poorly | IIIA | LUL | SCC | 12.76 | Y |
| LC-00095 | 74/M | 50 | Poorly | IB | RLL | SCC | 0.60 | N |
| LC-00304 | 55/M | 30 | Poorly | IIIA | RLL | SCC | 144 | Y |
| LC-00702 | 62/M | 45 | IB | LLL | SCC | 6.00 | N | |
| LC-00894 | 67/F | N | IA | RLL | ADC | 4.19 | N | |
| LC-00010 | 55/F | N | IB | RUL | ADC | 18.00 | N | |
| LC-00829 | 53/F | N | IA | LUL | ADC | 4.19 | N | |
| LC-00813 | 66/M | 45 | Poorly | IIIA | RUL | ADC | 65.45 | Y |
| LC-00444 | 43/F | N | IB | LLL | SCC | 13.74 | Y | |
| LC-00053 | 61/F | N | LUL | ADC | 7.85 | |||
| LC-00700 | 62/M | 30 | RLL | SCC | ||||
| LC-00831 | 59/F | N | Moderately | IB | RLL | ADC | 7.85 | N |
| LC-00195 | 51/M | 30 | Poorly | IIIA | LLL | ADC | 144.00 | Y |
| LC-00167 | 52/M | 30 | Poorly | IIB | RUL | ADC | 16.89 | Y |
| LC-00576 | 62/F | N | Poorly | IA | LUL | ADC | 15.08 | N |
| LC-00615 | 55/F | N | IA | LUL | ADC | 0.13 | N | |
| LC-00200 | 52/M | 20 | Well | IA | LUL | ADC | 1 | N |
| LC-00193 | 71/F | 0 | Poorly | IB | RUL | ADC | 5.78 | N |
TNM, tumor node metastasis; ADC, adenocarcinoma; SCC, squamous cell carcinoma; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; LLL, left lower lobe; RUL, right upper lobe. The blank space indicates no information.